These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2854736)

  • 1. Plasmapheresis in the treatment of the Guillain-Barré syndrome in childhood.
    Yoshioka M; Kuroki S; Mizue H
    Pediatr Neurol; 1985; 1(6):329-34. PubMed ID: 2854736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome in childhood: natural course and efficacy of plasmapheresis.
    Jansen PW; Perkin RM; Ashwal S
    Pediatr Neurol; 1993; 9(1):16-20. PubMed ID: 8452594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of plasmapheresis in childhood Guillain-Barré syndrome.
    Epstein MA; Sladky JT
    Ann Neurol; 1990 Jul; 28(1):65-9. PubMed ID: 2375635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of early beneficial response to plasma exchange in Guillain-Barré syndrome.
    Gruener G; Bosch EP; Strauss RG; Klugman M; Kimura J
    Arch Neurol; 1987 Mar; 44(3):295-8. PubMed ID: 3827680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
    Rudnicki S; Vriesendorp F; Koski CL; Mayer RF
    Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Guillain-Barré syndrome.
    Van der Meché FG
    Baillieres Clin Neurol; 1994 Apr; 3(1):73-94. PubMed ID: 7921592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guillain-Barré syndrome with nerve conduction blocks at multiple common entrapment sites that rapidly disappeared after plasmapheresis].
    Susuki K; Johkura K; Kawauchi Y; Hasegawa O; Kuroiwa Y
    Rinsho Shinkeigaku; 1998 Mar; 38(3):270-2. PubMed ID: 9711129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis.
    Vriesendorp FJ; Mayer RF; Koski CL
    Arch Neurol; 1991 Aug; 48(8):858-61. PubMed ID: 1898263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
    Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
    Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis in children with Guillain-Barré syndrome.
    Lamont PJ; Johnston HM; Berdoukas VA
    Neurology; 1991 Dec; 41(12):1928-31. PubMed ID: 1745351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
    Kuwabara S; Nakajima M; Moroo I; Hirayama K
    Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome: clinical and therapeutic observations.
    McKhann GM
    Ann Neurol; 1990; 27 Suppl():S13-6. PubMed ID: 2194419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis associated with a relapsing course in Guillain-Barré syndrome.
    Shanks DE; Lenn NJ
    Pediatr Neurol; 1989; 5(3):189-90. PubMed ID: 2742629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Guillain-Barré syndrome in aged patients: the effect of plasmapheresis.
    Yamashita S; Morinaga T; Matsumoto K; Sakamoto T; Kaku N; Matsukura S
    Intern Med; 1992 Nov; 31(11):1313-6. PubMed ID: 1295631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis versus plasma perfusion in acute Guillain-Barré syndrome.
    Morosetti M; Meloni C; Taccone Gallucci M; Rossini PM; Felicioni R; Palombo G; Boccasena P; Casciani CU
    ASAIO J; 1994; 40(3):M638-42. PubMed ID: 8555592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of plasmapheresis in acute Guillain-Barré syndrome.
    Piccolo G; Cosi V; Lombardi M; Poloni M; Ceroni M; Fornasari PM
    Ital J Neurol Sci; 1986 Jun; 7(3):349-52. PubMed ID: 3733414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group.
    Visser LH; van der Meché FG; Meulstee J; Rothbarth PP; Jacobs BC; Schmitz PI; van Doorn PA
    Neurology; 1996 Sep; 47(3):668-73. PubMed ID: 8797462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.